Clorox (NYSE:CLX – Get Free Report) updated its FY 2025 earnings guidance on Monday. The company provided EPS guidance of 6.950-7.350 for the period, compared to the consensus EPS estimate of 7.140. The company issued revenue guidance of $7.0 billion-$7.1 billion, compared to the consensus revenue estimate of $7.1 billion.
Clorox Stock Down 2.9 %
Shares of NYSE CLX traded down $3.98 during trading hours on Tuesday, hitting $134.42. The company had a trading volume of 1,168,694 shares, compared to its average volume of 1,289,125. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The firm’s 50 day moving average is $143.85 and its 200-day moving average is $154.69. Clorox has a 1-year low of $127.60 and a 1-year high of $171.37. The stock has a market capitalization of $16.56 billion, a P/E ratio of 36.76, a price-to-earnings-growth ratio of 2.62 and a beta of 0.60.
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing the consensus estimate of $1.57 by ($0.12). Clorox had a net margin of 6.38% and a return on equity of 316.87%. The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same quarter in the prior year, the firm earned $1.71 earnings per share. The firm’s revenue for the quarter was down 8.0% on a year-over-year basis. On average, analysts expect that Clorox will post 7.15 earnings per share for the current fiscal year.
Clorox Dividend Announcement
Analysts Set New Price Targets
CLX has been the topic of a number of analyst reports. JPMorgan Chase & Co. decreased their target price on shares of Clorox from $151.00 to $144.00 and set a “neutral” rating on the stock in a report on Tuesday. Royal Bank of Canada reiterated a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. Evercore ISI boosted their target price on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Citigroup dropped their price objective on shares of Clorox from $165.00 to $150.00 and set a “neutral” rating on the stock in a research note on Monday, April 14th. Finally, Wells Fargo & Company lowered their price target on Clorox from $145.00 to $142.00 and set an “equal weight” rating for the company in a research report on Tuesday. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $152.77.
View Our Latest Research Report on Clorox
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Recommended Stories
- Five stocks we like better than Clorox
- Stock Market Upgrades: What Are They?
- Microsoft Stock After Xbox Price Hike: Buy or Hold?
- Industrial Products Stocks Investing
- Top 3 Sectors Where Valuations Are Most Below Market Levels
- When to Sell a Stock for Profit or Loss
- Palantir Stock Drops Despite Stellar Earnings: What’s Next?
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.